CONFIDENTIAL TREATMENT REQUESTEDContribution Agreement • February 27th, 2015 • Glaxosmithkline PLC • Pharmaceutical preparations
Amended Novartis Disclosure Letter” means the Original Novartis Disclosure Letter, as amended and restated in the form set out in Schedule 3 to this Deed;
CONFIDENTIAL TREATMENT REQUESTEDShare and Business Sale Agreement • February 27th, 2015 • Glaxosmithkline PLC • Pharmaceutical preparations
Executed as a DEED by Marvelle Sullivan and Jonathan Emery on behalf of NOVARTIS AG } /s/ Marvelle Sullivan /s/ Jonathan Emery
NOVARTIS AG and GLAXOSMITHKLINE PLC DEED OF AMENDMENT AND RESTATEMENT relating to the IMPLEMENTATION AGREEMENT dated 22 April 2014 Freshfields Bruckhaus Deringer LLP London EC4Y 1HSGlaxosmithkline PLC • February 27th, 2015 • Pharmaceutical preparations
